The jury is still out on oestrogens and oestrogen/progestin and the heart [2] (multiple letters)
Date
2003
Authors
Cheifitz R.L.
Hough S.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
[No abstract available]
Description
Keywords
estrogen, gestagen, raloxifene, breast cancer, cardiovascular disease, cardiovascular risk, clinical trial, controlled clinical trial, dose response, drug indication, estrogen therapy, heart protection, high risk population, hormone substitution, human, ischemic heart disease, letter, patient selection, primary prevention, randomized controlled trial, risk assessment, stroke, thromboembolism, treatment indication, treatment outcome, Coronary Disease, Estrogen Replacement Therapy, Estrogens, Female, Humans, Progestins, Risk Factors, Treatment Failure
Citation
Cardiovascular Journal of South Africa
14
1
14
1